Home Healthcare Medical Devices Europe Home Infusion Therapy Market

Europe Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Products, Services), By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Last Updated: September 21, 2026 | Author: Debashree Bora | Format:

Market Overview

The Europe Home Infusion Therapy Market size was valued at USD 11.58 billion in 2025 and is projected to grow from USD 12.46 billion in 2026 to reach USD 22.39 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034).

An alternative to taking medication by mouth is infusion therapy, which is how the term is defined. The infusion process involves monitoring the administration of medication with the assistance of a sterile catheter inserted into a vein.

Home infusion therapy refers to giving an individual medication or biologicals through an intravenous or subcutaneous route while they live in their residence. The medication (such as antivirals or immune globulin, for example), the necessary piece of medical equipment (such as a pump), and the necessary medical supplies are required to carry out home infusion (for example, tubing and catheters). In a similar vein, nursing services are required to educate and train both the patient and the caregivers administering the infusion medications in the patient's home. Home infusion treatment frequently requires a significant contribution from visiting nurses. Typically, nurses will instruct the patient or the caregiver on how to self-administer the medication, educate the patient about the potential adverse effects of the treatment and the aims of therapy, and visit the patient occasionally to evaluate the infusion site and change the dressing. In most cases, the procedure of home infusion needs coordination among several different parties. These parties can include patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if necessary, home health organisations.

Europe Home Infusion Therapy Market Size

Download a Free Sample To learn more about this report.

Europe Home Infusion Therapy Market Segmentation Analysis

By Type

The Europe Home Infusion Therapy Market is segmented into Products and Services. Products include infusion pumps, intravenous administration sets, IV cannulas, needleless connectors, and other medical consumables required for administering therapies in home settings, while services include nursing care, therapy management, patient education, monitoring, and clinical support. The growing preference for home-based healthcare, increasing prevalence of chronic diseases, aging populations, and the need to reduce hospital stays are supporting demand for both product and service offerings. Products form the essential equipment base for home infusion treatment, while services help ensure safe administration, treatment adherence, and appropriate patient monitoring outside traditional healthcare facilities.

Increasing healthcare costs, improvements in infusion technologies, expansion of home healthcare programs, and greater patient preference for receiving appropriate treatments at home are supporting market growth. Demand for products is driven by the need for reliable and portable infusion equipment and consumables, while services are gaining importance as healthcare providers seek to deliver coordinated clinical support for patients receiving long-term therapies. The expansion of outpatient care, increasing availability of trained home healthcare professionals, and growing use of remote monitoring technologies are expected to further support the adoption of home infusion therapy across Europe.

Europe Home Infusion Therapy Market Size By Segments

Request Customizationto receive a tailored report.

By Product

The Europe Home Infusion Therapy Market is segmented into Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. Infusion pumps enable controlled and accurate delivery of medications, fluids, and nutrients and are particularly useful for therapies requiring precise administration rates. Intravenous sets facilitate the delivery of infusion solutions from containers or pumps to patients, while IV cannulas provide vascular access for intravenous treatment. Needleless connectors allow safer connections between infusion components and can reduce the need for repeated needle access. Product selection depends on therapy requirements, treatment duration, patient condition, infusion volume, and clinical protocols.

Rising adoption of home-based treatment, increasing prevalence of chronic diseases, growing demand for portable medical technologies, and the expansion of home healthcare services are supporting demand across all product categories. Infusion pumps are gaining importance due to their ability to provide programmable and controlled administration, while intravenous sets, IV cannulas, and needleless connectors benefit from the growing number of patients requiring repeated or long-term infusion treatment. Continued product innovation, increasing emphasis on patient safety, and the need to simplify home-based therapy administration are expected to create further opportunities for infusion therapy product manufacturers across Europe.

By Application

The Europe Home Infusion Therapy Market is segmented into Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals. Anti-infective therapy is used for patients requiring prolonged intravenous treatment, while endocrinology applications include therapies requiring regular medication administration and monitoring. Hydration therapy supports patients who require fluid and electrolyte replacement, while selected chemotherapy treatments can be delivered in home settings under appropriate clinical supervision. Enteral and parenteral nutrition support patients who cannot obtain sufficient nutrition through normal oral intake, while specialty pharmaceuticals include complex therapies requiring specialized administration, monitoring, and patient support.

Rising prevalence of chronic diseases, increasing aging populations, growing demand for convenient treatment options, and efforts to reduce hospital utilization are supporting home infusion applications across Europe. Anti-infective treatments, hydration therapy, and nutritional applications are benefiting from the expansion of home healthcare, while specialty pharmaceuticals and selected chemotherapy applications are creating opportunities as healthcare systems develop more advanced home treatment programs. Increasing patient preference for appropriate care in familiar home environments, improvements in infusion technology, remote monitoring capabilities, and the availability of specialized healthcare professionals are expected to support continued adoption across these application areas.

Europe Home Infusion Therapy Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Europe home infusion therapy market is divided into the UK, Germany, France, Italy, and the Rest of Europe, based on country. According to the World Health Organization, Europe sees 3.7 million new cancer cases and 1.9 million cancer deaths each year, making it the second most common disease after heart disease. This has resulted in increased demand for physician-directed home infusions and related services, which is both cost-effective and less taxing on healthcare facilities.

List of Key and Emerging Players in Europe Home Infusion Therapy Market

OMT GmbH & Co. KG
Licher Medical Therapy (LMT)
Sciensus
Mediq
Hala Altab Medical Car
Enayati Home Health Care
ORKYN
ICU Medical
JMS CO., LTD.
Smiths' Medical, Inc.

Key Industry Developments

May 2026
B. Braun introduced an advanced connected infusion management solution integrating smart infusion pumps with digital monitoring capabilities to support safer home infusion therapy across Europe.
April 2026
Fresenius Kabi expanded its home infusion portfolio by introducing new elastomeric infusion pumps and patient support services for long-term antimicrobial, oncology, and nutritional therapies.
January 2026
Baxter International expanded its European home care portfolio with enhanced digital monitoring capabilities for home infusion therapies, improving remote patient management and treatment adherence.
October 2025
ICU Medical expanded its ambulatory infusion pump portfolio in Europe with new portable infusion systems designed for oncology, pain management, and antibiotic therapy administered in home settings.

Report Scope

Segmentation

By Type 2
  • Products
  • Services
By Product 4
  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
By Application 7
  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
Competitive Coverage OMT GmbH & Co. KG · Licher Medical Therapy (LMT) · Sciensus · Mediq · Hala Altab Medical Car
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Europe Home Infusion Therapy market size is projected to reach USD 22.39 Billion by 2034.

The Market of Europe Home Infusion Therapy growing at a CAGR of 7.6% from (2026–2034).

The Infusion pumps segment is expected to dominate over the forecast period.

OMT GmbH & Co. KG, Licher Medical Therapy (LMT), Sciensus, Mediq, Hala Altab Medical Car, Enayati Home Health Care, ORKYN, ICU Medical, JMS CO., LTD., Smiths' Medical, Inc., are the prominent players in the Europe Home Infusion Therapy Market.

The growing elderly population & increasing demand for long-term care are some key drivers supporting the growth of the Europe Home Infusion Therapy Market.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: